Skip to main content
Download PDF
  • Research article
  • Open access
  • Published:

Prevalence of depression and associated risk factors among persons with type-2 diabetes mellitus without a prior psychiatric history: a cross-sectional study in clinical settings in urban Nepal

BMC Psychiatry volume 13, Article number: 309 (2013) Cite this article

Abstract

Background

Diabetes is a growing health problem in South Asia. Despite an increasing number of studies exploring causal pathways between diabetes and depression in high-income countries (HIC), the pathway between the two disorders has received limited attention in low and middle-income countries (LMIC). The aim of this study is to investigate the potential pathway of diabetes contributing to depression, to assess the prevalence of depression, and to evaluate the association of depression severity with diabetes severity. This study uses a clinical sample of persons living with diabetes sequelae without a prior psychiatric history in urban Nepal.

Methods

A cross-sectional study was conducted among 385 persons living with type-2 diabetes attending tertiary centers in Kathmandu, Nepal. Patients with at least three months of diagnosed diabetes and no prior depression diagnosis or family history of depression were recruited randomly using serial selection from outpatient medicine and endocrine departments. Blood pressure, anthropometrics (height, weight, waist and hip circumference) and glycated hemoglobin (HbA1c) were measured at the time of interview. Depression was measured using the validated Nepali version of the Beck Depression Inventory (BDI-Ia).

Results

The proportion of respondents with depression was 40.3%. Using multivariable analyses, a 1-unit (%) increase in HbA1c was associated with a 2-point increase in BDI score. Erectile dysfunction was associated with a 5-point increase in BDI-Ia. A 10mmHg increase in blood pressure (both systolic and diastolic) was associated with a 1.4-point increase in BDI-Ia. Other associated variables included waist-hip-ratio (9-point BDI-Ia increase), at least one diabetic complication (1-point BDI-Ia increase), treatment non-adherence (1-point BDI-Ia increase), insulin use (2-point BDI-Ia increase), living in a nuclear family (2-point BDI-Ia increase), and lack of family history of diabetes (1-point BDI-Ia increase). Higher monthly income was associated with increased depression severity (3-point BDI-Ia increase per 100,000 rupees, equivalent US$1000).

Conclusions

Depression is associated with indicators of more severe diabetes disease status in Nepal. The association of depression with diabetes severity and sequelae provide initial support for a causal pathway from diabetes to depression. Integration of mental health services in primary care will be important to combat development of depression among persons living with diabetes.

Peer Review reports

Background

Diabetes mellitus is a growing public health concern in Asia, where more than 110 million people are living with diabetes, and more than 1.0 million people die annually in the region from the disorder [1]. In South Asia, greater population-level affluence is associated with an increase in health compromising behaviors related to chronic diseases such as cardiovascular disease, cancer, and diabetes [2]. With prevalence greater than 6% and growing rapidly in South Asia, the expected prevalence increase in India is 171% from 2007 to 2025 [1].

Worldwide, the prevalence of mood and anxiety disorders is higher among persons living with diabetes compared to those without diabetes [3–5]. In a meta-analysis of 42 published studies comprised of 21,351 adults, the prevalence of major depression in people with diabetes was 11% and the prevalence of clinically relevant depression was 31% ([4], c.f. [6]). The bidirectional relationship of diabetes with depression is presented by many studies [7–9]. Co-morbid depression among persons living with diabetes is associated with poor markers of diabetes control, such as glycemic control [10], retinopathy, nephropathy, neuropathy, micro-vascular complications and sexual dysfunction [11]. Depression is more prevalent among females with diabetes than males with diabetes [12], patients with type 2 versus type 1 diabetes [13] and those who are treated with insulin [14]. Depression in patients with both type 1 and type 2 diabetes is associated with psychosocial stressors of chronic medical condition [15]. An increased risk of type 2 diabetes in individuals with depression is likely due to increased counter-regulatory hormone release and action, alterations in glucose transport function, and increased immune-inflammatory activation [16]. Patients with diabetes have lower quality of life ratings, with the greatest quality reduction when depression and diabetes are comorbid [17, 18].

The association of depression and diabetes has been reported in South Asia. In India, a hospital-based study suggested a prevalence of depression ranging from 8.5% to 32.5% depending upon the scales used [19]. In India, depression among persons living with diabetes has been associated with age, obesity, increased pill burden and complications of neuropathy and retinopathy [20], as well as somatic symptoms among females, and genital symptoms among males [19]. In Pakistan, history of gestational diabetes mellitus, nuclear family, obesity, marital status, history of smoking and history of high blood pressure were risk factors for depression among type 2 diabetes mellitus patients [21]. In Bangladesh, prevalence rates of depression among persons living with diabetes ranges from 28-34% [12, 22, 23] with differences by gender, e.g. 22% prevalence in males and 35% prevalence in females [12]. Risk factors in Bangladesh include being unmarried, insulin use, and poor glycemic control.

In Nepal, no studies to date have investigated the prevalence of depression and diabetes comorbidity. The prevalence of diabetes in Nepal is estimated to be 436,000 (2%) in 2000 and it is projected to affect 1,328,000 persons (10% prevalence) in 2030 [24]. However, in another study of a semi-urban sample, the current prevalence of type 2 diabetes mellitus in Nepal was identified as 9.5% with impaired fasting glucose having a prevalence of 19.2%. Prevalence rates were highest among middle-aged and older men [25]. Other studies in Nepal have suggested prevalence rates of 15% among persons 20–39 years old and 19% among 40 years and older [26]. In Bir Hospital, the central government hospital in Kathmandu, diabetes was reported to be the seventh most common reason for medical admissions with 2.5% prevalence [27], whereas in Tribhuvan University Teaching Hospital in Kathmandu, diabetes comprised 9.5% of total medical admissions per year [28].

The aim of this cross-sectional study was to identify the prevalence of depression among type 2 diabetes patients not previously diagnosed with a mood disorder, as well as to identify risk factors for depression among persons with diabetes. We were specifically interested in the causal pathway from diabetes to depression. Therefore exclusion criteria were designed to minimize the number of participants for whom depression may have preceded diabetes. The study focuses on clinical populations with the goal of providing prevalence estimates and risk factor associations to guide clinical prevention and management of mood disorders among persons with diabetes who do not have a psychiatric history.

Methods

Setting

Nepal is among the world’s poorest countries [29] with a GDP of $260 per year, which is unequally divided. Nepal recently endured the People’s War fought between the Communist Party of Nepal (Maoists) and government security forces from 1996 through 2006. Thapa and Sijapati [30] state that the economy of Nepal has favored the urban, the rural rich, and elites. Moreover, economic and political power is centralized in the capital, with minor representation from rural regions. In addition, Nepal tops the gender inequality index in South Asia, with a greater workload burden for women than men, lower literacy rates, earlier average mortality, and a myriad of discriminatory laws [31]. Ethnic inequality, institutionalized through the Hindu caste system, is represented by the lack of ethnic diversity in government positions. In 2001, 98% of people passing civil service examination were from Hindu hill groups, even though they constitute 29% of the population [30].

Community-based epidemiological studies in Nepal suggest a prevalence of depression ranging from 28% to 41% [32, 33], with rates considerably greater among women, members of lower caste (Dalit) groups [34, 35], the elderly and medically ill. While these high rates are influenced by the recent history of political violence, a study examining depression pre and post-war found no change in rates due to conflict related violence. This suggests that endemic poverty, lack of healthcare, and discrimination against women and persons from lower castes are chronic risk factors for poor mental health predating the conflict [33]. One study examined the association of psychosomatic complaints among persons with depression, finding that two-thirds of psychosomatic complaints were either medical comorbidities or medical conditions that cause both somatic complaints and psychiatric problems. Diabetes was a common comorbidity with depression [36].

Participants

A cross-sectional study was conducted in three urban medical centers in Nepal’s capital city Kathmandu: (1) medical university (Tribhuvan University Teaching Hospital), (2) private medical college (Nepal Medical College) and (3) private hospital (Om Hospital and Research Center). The diversity of sites created the ability to obtain a range of participants across socioeconomic levels from 75 districts of Nepal.

Inclusion and exclusion criteria

Every third patient with type 2 diabetes from the endocrine and medicine outpatient departments in all three centers was recruited. Patients were required to have a diagnosis of at least three months duration. Patients with chronic medical illnesses before detection of diabetes, pregnant women, and patients with a psychiatric history were excluded. Criteria for psychiatric history included history of taking anti-depressant medication, any prior diagnosis of depression, and patients with a family history of depression or mental illness. Patients with a family history of depression or other mental illness were excluded because the study examined depression as a secondary condition to diabetes. To investigate risk factors for current depression symptoms among anti-depressant naïve patients, patients currently taking anti-depressant medication were excluded because medication may reduce depression symptom burden, thus reducing the association of risk factors with current symptoms.

Ethical approval

The study was conducted from June 2011 through June 2012 and participant recruitment was active from November 2011 through April 2012. Ethical approval was obtained from the Nepal Health Research Council and the Bangladesh Diabetes Association Ethical Review Committee. Permission was obtained from hospital representatives to allow recruitment at their respective facilities. Participants were provided with informed consent forms. If level of literacy was a concern, the consent form was read aloud to the participants.

Instruments

In previous studies, the Beck Depression Inventory (BDI) has been used as a tool to accurately assess depressive symptoms among patients with type 2 diabetes mellitus [37, 38]. The Nepali version of Beck Depression Inventory (BDI-Ia) was used for assessing depression among persons living with diabetes. The BDI-Ia was validated for use with Nepali speakers with sensitivity 0.73 and specificity of 0.91 at a cut-off score of 20 indicating clinical levels of symptoms severity [35, 39, 40]. Test re-test reliability was 0.90 and internal reliability was 0.92.

A semi-structured, pre-tested questionnaire was administered by the interviewers to collect information on socio-demographic characteristics, disease variables, and behavioral characteristics. The questionnaire was prepared in English and translated into Nepali language and was reviewed by Nepali psychiatrists, endocrinologists, epidemiologists, and biostatisticians. Pre-testing of the questionnaire was performed to gather information about understandability, time consumed by each question, consistency among related variables and acceptability. After reviewing the outcome of pre-testing, changes were incorporated accordingly. Medical interns and nurses in the outpatient departments were given a short course on data collection using the instruments, including anthropometric measurements (BMI, WHR), clinical parameters (blood pressure), and use of the Nepali BDI-Ia. Height, weight, waist circumference and hip circumference were measured using standard clinical protocols.

After the interviews, patients were then taken to the hospital laboratory for blood draws for analysis of HbA1c using 2 ml of venous blood. The local supervisor, a professor of epidemiology, reviewed all procedures and notation at the end of each day.

Statistical analyses

Sample size was estimated using the prevalence of depression among persons with type 2 diabetes from a recent study conducted in Bangladesh at a tertiary care center [22]. Using an estimated prevalence of 35%, 95% confidence intervals, and absolute precision of 5%, a sample size of 348 was determined. This study recruited 385 patients.

Statistical comparisons of socio-demographic variables between male and female patients were conducted using chi-squared tests and t-tests for categorical and continuous variables respectively. Odds ratios (OR) with 95% confidence interval (CI) were calculated for categorical comparisons. All tests were two-tailed and with p < 0.05 considered statistically significant. Bivariate and multivariable statistical analyses were conducted using linear regression. Regression coefficients (β) and 95% CI are presented for multivariable and bivariate linear regressions with total BDI-Ia score as the dependent outcome. Multiple linear regressions were performed to adjust for potential confounding factors.

The final multivariable model included sex, age, religion, ethnicity/caste, marital status, years of education, monthly income, family type, number of family members, parental history of DM, family history of HTN, personal history of HTN, smoking, alcohol use, treatment non-adherence, DM complications, erectile dysfunction, systolic blood pressure, diastolic blood pressure, waist-hip-ratio, and glycated hemoglobin. These variables were included in the model because of a known history of association with depression in Nepal or other study populations. Body-mass-index was not included in the multivariable model because it was not statistically significant in bivariate analysis with depression and because of high collinearity with waist-hip-ratio. Although systolic and diastolic blood pressures are collinear, when entered in the same multivariable model, they both remained significant. Therefore, both were kept in the model.

Results

Sample characteristics

The sample included 48.3% men and female 51.7% women (see Tables 1 and 2). The mean ± standard deviation (SD) for age was 52.0 ± 13.1 years, with males 6 months older than females, which was not a statistically significant difference (t = 0.4, df = 383, p = 0.7). The majority of participants practiced Hinduism (76.6%) and 17.4% practiced Buddhism. Nearly half (45%) of the participants belonged to high caste groups (Bahun, Chhetri), more than two-thirds of participants were married (68.6%), and the majority lived in nuclear families (79.2%). Among total participants, 47.5% had a family size less than five members. Mean total years of formal education was 5.8 ± 6.7, with only 52% of participants having any formal education and only 20% with high school graduate equivalent degrees. Illiteracy was greater among female (25.6%) than males (18.1%). Median monthly income of participants was Nepali Rupiyaa 10,000, range 0–200,000, (NRs. 100 = US$1). Median family income was Rs. 30,000, range Rs. 0 – 500,000.

Table 1 Categorical demographics
Full size table
Table 2 Continuous demographics
Full size table

Depression

The mean and standard deviation for total BDI-Ia score of participants was 19.8 ± 8.0. Male and female scores were 18.6 ± 7.6 and 20.9 ± 8.1 respectively. Women had significantly greater BDI-Ia scores compared to men (t = -2.74, df = 383, p < 0.01). The number of participants with clinical depression (≥20 BDI-Ia score) was 155 (40.3% of the total sample). Among depressed patients, 48.2% were female and 31.7% were male. BDI-Ia scores above the cut-off were significantly associated with sex (χ 2 = 10.91, df = 383, p < 0.001).

In bivariate analyses, socio-demographic, economic, anthropometric, clinical and biochemical parameters were significantly associated with BDI-Ia score (See Tables 3 and 4). Female sex associated with a β = 2.2 point in total BDI-Ia score compared to men (df = 383, p = 0.006). Participants having family history of diabetes showed a protective effect of β = -2.7 (95% CI: -4.3,-1.0, df = 383, p < 0.01) compared to persons without family history of diabetes (p = 0.02). Patients with at least one diabetic complication had a 3.6 point higher BDI-Ia score (95% CI: 2.0, 5.2, df = 383, p < 0.001) and men with erectile dysfunction had greater BDI-Ia scores (β: 8.9; 95% CI: 4.4, 13.4, df = 185, p < 0.001). As the duration of diagnosis of diabetes increased BDI-Ia score decreased (β: -0.1; 95% CI: -0.3,-0.01, df = 383, p = 0.03), i.e. persons who were further along in the disease course, patients reported fewer depression symptoms. Other significant characteristics were systolic BP (β: 0.3; 95% CI: 0.3, 0.4, df = 383, p < 0.001), diastolic BP (β: 0.4; 95% CI: 0.4, 0.5, df = 383, p < 0.001), and WHR (β: 18.5; 95% CI: 7.7, 29.4, df = 383, p < 0.001). BMI (β: -0.01; 95% CI: -0.3,-0.01, df = 383, p = 0.90) was not significant in bivariate comparisons.

Table 3 Bivariate regression of categorical variables with depression symptom severity (total BDI-Ia score)
Full size table
Table 4 Bivariate regression of continuous variables with depression symptom severity (total BDI Score)
Full size table

In the multivariable regression, clinical and biochemical parameters as well as anthropometrics were significantly associated with depression symptom severity. An increase of 1 unit (%) HbA1c was associated with a BDI-Ia increase of 2.08 (See Table 5). An increase of 10 mmHg in systolic and diastolic blood pressure was associated with an increase of 1.3 and 1.4 of BDI-Ia scores, respectively. An increase of 0.1 in waist-hip-ratio was associated with a 1 point increase in BDI-Ia score. Any diabetic complication was associated with a BDI-Ia score increase of 1.2, whereas erectile dysfunction was associated with a 4.74 BDI-Ia score increase. Regarding treatment parameters, insulin use compared to oral or other treatments was associated with a 1.74 BDI-Ia score increase, and adherence was associated with a 1.05 BDI-Ia score decrease. Affluence was associated with greater depression severity. An increase of NRs. 100,000 (US$1,000) per month in personal income predicted an increase of 3 points on total BDI-Ia score. Other significant parameters included known family history of hypertension (β = -1.5, df = 362, p = .01) and living in a nuclear family (β = 1.6, df = 362, p = .03) as opposed to joint-extended family. Given the greater depression severity among persons early in the diagnosis and treatment process, a sensitivity analysis of diagnoses within the past 3 years was conducted. However, no additional risk factors were identified.

Table 5 Multivariable Regression for Depression Symptom Severity (Total BDI-Ia Score)
Full size table

Discussion

This was a cross-sectional study conducted in three clinical settings of urban Nepal. The aim of the study was to find the prevalence of depression among persons living with diabetes and to identify probable risk factors. Patients who were diagnosed with diabetes at least three months prior to the study were included. Patients with other chronic medical illnesses before detection of diabetes, pregnant women with diabetes, people having psychiatric problems before diagnosis of diabetes, people who were taking anti-depressants and people who had a family history of depression were excluded. The goal of these criteria was to minimize the likelihood of depression as a pre-existing condition and instead identity depression that occurred secondary to diabetes.

In the present study, the proportion of participants with BDI-Ia scores above the clinically validated cutoff in Nepal (BDI ≥ 20) was 40.3%. This rate is comparable to prevalence of depression (36.6%), as reported in a worldwide meta-analysis of studies among persons with diabetes in clinical settings [41]. The rate is higher than that observed in the United States, where prevalence of depression among persons with diabetes ranges from 2%-28% [14.] Our observed rate is comparable to Mexican-born Americans in the Texas who display a 40% prevalence rate [42] and comparable to a German study with a depression prevalence among persons with diabetes of 41.9% also using the BDI [43]. The observed rate in this study was at the upper range of other studies conducted in South Asia. Hospital-based studies from India showed prevalence ranging from 8.5%-32.5% [19]. Asghar et al. did a community based study in Bangladesh, which showed 27.9% depression among type 2 diabetes patients [12]. A tertiary hospital based study conducted in Bangladesh showed 34.8% depression in persons living with diabetes [22].

Risk indicators for depression in patients with type 2 diabetes

As expected, complications of diabetes were significantly associated with depression. This has been observed across most studies of depression and diabetes in both high [44, 45] and low-income settings including South Asia [21, 22]. Erectile dysfunction was one of the strongest predictors of depression, which is consistent with De Groot et al.[11] and Lustman et al.,[10]. In this study family history of diabetes was associated with lower depressive symptoms than those who had no family history. While the study does not have quantitative or qualitative data to illuminate the association, it is speculated that family history may reduce fear and anxiety related to the disorder as well as normalize the experience, resulting in lower psychological distress. As with other studies, insulin use predicted greater depression, with insulin likely a proxy for greater disease severity [4, 14, 22, 41, 46–49]. The study showed non-adherence to at least one aspect of the diabetes management plan (life style, diet, medication) was strongly associated (p < 0.001) with depression, consistent with studies in high-income countries [3, 17, 50, 51]. Studies showed not checking blood sugar [3], lack of regular exercise [45], lack of medical vigilance, and lack of dietary modification [49] were associated with depression. Time since diabetes diagnosis was inversely associated with depression severity, suggesting that the early experience of the disease is the period of greatest psychological distress and adjustments in lifestyle. High blood pressure, either systolic or diastolic, was associated with greater depression severity, similar to other findings [21, 22]. Glycemic status (glycated hemoglobin) was consistently associated with depression in almost all studies done so far in research related to depression among type 2 diabetes [10, 22, 47, 52–55]. HbA1c was strongly associated with depression in this study as well, which is also a likely proxy for disease severity.

A number of risk factors associated with depression in Nepal were not significantly associated with depression among this clinical population with diabetes. For example, gender was not a significant predictor of depression among persons with diabetes in the multivariable regression model. This contrasts with community studies of depression that show a consistently greater prevalence among Nepalese women compared to men [32, 33]. In a study of women with diabetes in India, Weaver and Hadley [56] found that not fulfilling gender-specific social roles predicted greater levels of depression. In this sample, there may be no gender differences between men and women because diabetes impairs gender-role performance for both sexes, as suggested by greater depression among men living with diabetes with erectile dysfunction. Diabetes may have comparable functional consequences for both genders, whereas women in Nepal are more vulnerable socially even in the absence of physical disease [34].

Age is a strong predictor of depression in the general community in Nepal [32, 33, 35]. However, it was not a significant predictor in this Nepali clinical population with diabetes. Age has shown an inconsistent relationship with depression and in people with diabetes with depression in a number of studies: Goldney et al. also did not find an association of age with depression among persons living with diabetes [17]. Ravel et al. did found depression to be strongly associated with age above 54 years [20].

In this study, caste and ethnicity were not significantly associated with depression. However, community-based samples in rural Nepal show a greater preponderance of depression among low-caste Dalit groups [3, 35, 57–59]. In other countries, ethnic minorities with diabetes display more depression than majority groups [44, 48, 60, 61]. Marital status also was not significant, despite being a predictor in rural Nepal and in studies of persons living with diabetes in other countries (Pakistan) [21]. This study showed participants from urban area were more depressed (p < 0.001) which is not consistent with other studies where rural population was more depressed [20, 51]. It is important to note that the prevalence of depression in this sample of persons living with diabetes (40%) is comparable to rates of depression observed among other risk groups in Nepal such as low caste Dalit groups (BDI-Ia-based depression prevalence, 50%) [35], populations with high political violence exposure including both adult civilians (Dang district, BDI-Ia-based depression prevalence, 43%) [32] and child soldiers (depression prevalence, 53%) [59], and populations with high rates of structural violence including poverty, lack of education, lack of health care, and high rates of gender discrimination (Jumla district, BDI-based depression prevalence, 41%) [33].

In this study, greater personal income was associated with greater depression. Although this study showed participants with high income were more depressed (p < 0.01) than their lower income counterparts, Bell et al.[50], Egede et al.[60], Everson et al.[61] suggests patients with lower income have more depression. In India, mixed methods research by Mendenhall and colleagues [62] suggests that depression is greater among low-income persons with diabetes, likely influenced by both greater financial stressors and also by impaired access to diabetes care. In urban Nepal, wealth may be a proxy for poorer health overall. Whereas obesity, metabolic syndrome, and diabetes are greater risks among poor populations in high income countries, affluence is associated with these poor health outcomes in some studies in South Asia [2].

However, the rapid economic transitions in India are demonstrating that high-income groups are able to mobilize behavioral and medical resources while a growing burden of chronic health problems falls upon the middle and lower class, which is the pattern observed in high-income countries [63, 64]. Therefore, wealth may be a proxy for poor health habits, poor nutrition, limited exercise, excessive caloric intake, and smoking and drinking [65] at a specific moment in time in Nepal as the burden shifts to other groups. Alternatively, the selection criteria may have confounded the association of wealth and depression, as discussed in the limitations section below.

The present study did not reveal any association between behavioral characteristics of tobacco, alcohol, and other drug use. However, this may be because personal income was a stronger proxy for a constellation of poor behaviors in this population. Most other studies have shown an association of these behaviors with depression among persons living with diabetes [17, 21]. One reason that smoking may not be associated with poorer outcomes is the epidemic of respiratory disorders in Kathmandu given the overwhelming burden of pollution in the city. The present study showed an association between waist hip ratio and depression (p = 0.001), which is consistent with findings from Lustman et al.[10] and Larijani et al.[43].

Limitations

This study has a number of limitations. The main limitation is the generalizability of findings based on the sample. The goal was to identify persons with least likelihood of pre-diabetes depression. While this is helpful to consider the pathway from diabetes to depression and useful to demonstrate the high rate of mental health problems in persons with no prior history, it does confound some of the risk factor associations reported. The association between higher economic status and depression may be the result of excluding persons with prior depression, who are more likely to be low socioeconomic status given the high rates of depression in this population. Moreover, this study does not provide new information on the pathway from depression to diabetes. Further information on this group is needed to explore how mental health treatment can interrupt the transition from psychiatric to endocrine morbidity. Ultimately, studies that include comparisons of community residing persons with and without diabetes and depression rates and risk factors is needed to determine pathways and points of intervention. The strong association of sociobehavioral risk factors with depression among this group also highlights the need for models looking at direct and indirect effects of social marginalization with multiple mediation through physical health morbidity.

Conclusion

Depression is associated with indicators of more severe diabetes disease status in Nepal. The associations of depression with diabetic severity and sequel provide initial support for a causal pathway from diabetes to depression in Nepal. Integration of mental health services in primary care will be an important factor in preventing the development of depression among diabetes patients. Concealed depression among type-2 diabetes patients needs to be assessed in every diabetes care setting. Stepped and collaborative care models for treatment [66, 67] of diabetes and depression should be explored for treatment options in Nepal and other low-income countries [23]. Moreover, education about the connection between physical health and mental health, which has been used in high-income settings [68], should be considered for psycho-education programs within this population. Cognitive Behavior Therapy (CBT) with a focus on the connection between mind and body has been adapted for use with Nepali populations [69] and should be considered for studies with patients suffering from comorbid depression and diabetes in Nepal. With lifestyle changes and increasing affluence, the risk of diabetes will likely increase on a population level. More research is needed to determine public health measures to combat greater non-communicable health risks in Nepal. Mental health, obesity, and metabolic disorders have common risk factors therefore common solutions should be pursued rather than separate approaches to prevention of mental and physical health problems [70].

References

  1. Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, Hu FB: Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009, 301 (20): 2129-2140. 10.1001/jama.2009.726.

    Article  CAS  PubMed  Google Scholar 

  2. Ghaffar A, Reddy KS, Singhi M: Burden of non-communicable diseases in South Asia. BMJ. 2004, 328 (7443): 807-810. 10.1136/bmj.328.7443.807.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Lin EH, Katon W, Von Korff M, Rutter C, Simon GE, Oliver M, Ciechanowski P, Ludman EJ, Bush T, Young B: Relationship of depression and diabetes self-care, medication adherence and preventive care. Diabetes Care. 2004, 27 (9): 2154-2160. 10.2337/diacare.27.9.2154.

    Article  PubMed  Google Scholar 

  4. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ: The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001, 24 (6): 1069-1078. 10.2337/diacare.24.6.1069.

    Article  CAS  PubMed  Google Scholar 

  5. Lin EH, Korff MV, Alonso J, Angermeyer MC, Anthony J, Bromet E, et al: Mental disorders among persons with diabetes–results from the World Mental Health Surveys. J Psychosom Res. 2008, 65 (6): 571-580. 10.1016/j.jpsychores.2008.06.007.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Knol MJ, Twisk JWR, Beekman ATF, Heine RJ, Snoek FJ, Pouwer F: Depression as a risk factor for the onset of type 2 diabetes mellitus.Ameta-analysis. Diabetologia. 2006, 49: 837-845. 10.1007/s00125-006-0159-x.

    Article  CAS  PubMed  Google Scholar 

  7. Mezuk B, Eaton WW, Albrecht S, Golden SH: Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008, 31 (12): 2383-2390. 10.2337/dc08-0985.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Saydah SH, Brancati FL, Golden SH, Fradkin J, Harris MI: Depressive symptoms and the risk of type 2 diabetes mellitus in a US sample. Diabetes Metab. Res. 2003, 19: 202-208. 10.1002/dmrr.353.

    Article  Google Scholar 

  9. Zhang X, Norris SL, Gregg EW, Cheng YJ, Beckles G, Kahn HS: Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol. 2005, 161 (7): 652-666. 10.1093/aje/kwi089.

    Article  PubMed  Google Scholar 

  10. Lustman PJ, Anderson RJ, Freedland KE, Groot M, Carney RM, Clouse RE: Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care. 2000, 23: 934-942. 10.2337/diacare.23.7.934.

    Article  CAS  PubMed  Google Scholar 

  11. De Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ: Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001, 63 (4): 619-630.

    Article  CAS  PubMed  Google Scholar 

  12. Asghar S, Hussain A, Ali SM, Khan AK, Magnusson A: Prevalence of depression and diabetes: a population-based study from rural Bangladesh. Diabet Med. 2007, 24 (8): 872-877. 10.1111/j.1464-5491.2007.02136.x.

    Article  CAS  PubMed  Google Scholar 

  13. Shaban MC, Fosbury J, Kerr D, Cavan DA: The prevalence of depression and anxiety in adults with type 1 diabetes. Diabet Med. 2006, 23 (12): 1381-1384. 10.1111/j.1464-5491.2006.02012.x.

    Article  CAS  PubMed  Google Scholar 

  14. Li C, Ford ES, Strine TW, Mokdad AH: Prevalence of depression among U.S. adults with diabetes: findings from the 2006 behavioral risk factor surveillance system. Diabetes Care. 2008, 31: 105-107.

    Article  PubMed  Google Scholar 

  15. Talbot F, Nouwen A: A review of the relationship between depression and diabetes in adults: is there a link?. Diabetes Care. 2000, 23 (10): 1556-1562. 10.2337/diacare.23.10.1556.

    Article  CAS  PubMed  Google Scholar 

  16. Musselman DL, Betan E, Larsen H, Phillips LS: Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry. 2003, 54 (3): 317-329. 10.1016/S0006-3223(03)00569-9.

    Article  PubMed  Google Scholar 

  17. Goldney RD, Phillips PJ, Fisher LJ, Wilson DH: Diabetes, depression and quality of life: a population study. Diabetes Care. 2004, 27: 1066-1070. 10.2337/diacare.27.5.1066.

    Article  PubMed  Google Scholar 

  18. Alonso J, Angermeyer MC, Bernert S, et al: Disability and quality of life impact of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand. 2004, 420 (1): 38-46.

    Google Scholar 

  19. Chaudhry R, Mishra P, Mishra J, Parminder S, Mishra BP: Psychiatric morbidity among diabetic patients: a hospital-based study. Ind Psychiatry J. 2010, 19: 47-49. 10.4103/0972-6748.77637.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Raval A, Dhanaraj E, Bhansali A, Grover S, Tiwari P: Prevalence & determinants of depression in type 2 diabetes patients in a tertiary care center. Indian J Med Res. 2010, 132: 195-200.

    PubMed  Google Scholar 

  21. Perveen S, Otho MS, Siddiqi MN, Hatcher J, Rafique G: Association of depression with newly diagnosed type 2 diabetes among adults aged between 25 to 60 years in Karachi, Pakistan. Diabetol Metab Syndr. 2010, 2: 17-10.1186/1758-5996-2-17.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Rahman M, Rahman MA, Flora MS, Rakibuz-Zaman M: Depression and associated factors in diabetic patients attending an urban hospital of Bangladesh. Intern J Collaborative Res Intern Med Public Health. 2011, 3 (1): 65-76.

    Google Scholar 

  23. Roy T, Lloyd C, Parvin M, Mohiuddin KG, Rahman M: Prevalence of co-morbid depression in out-patients with type 2 diabetes mellitus in Bangladesh. BMC Psychiatry. 2012, 12 (1): 123-10.1186/1471-244X-12-123.

    Article  PubMed  PubMed Central  Google Scholar 

  24. World Health Organization: Prevalence of diabetes in the South-East Asia Region. 2010, http://www.who.int/diabetes/facts/world_figures/en/,

    Google Scholar 

  25. Ono K, Limbu YR, Rai SK, Kurokawa M, Yanagida J, Rai G, Gurung N, Sharma M, Rai CK: The prevalence of type 2 diabetes mellitus and impaired fasting glucose in semi-urban population of Nepal. Nepal Med Coll. 2007, 9 (3): 154-156.

    Google Scholar 

  26. Bhattarai MD, Singh DL: Learning the lessons-preventing type 2 diabetes in Nepal. Diabetes voice. 2007, 52 (2): 9-11.

    Google Scholar 

  27. Singh DL, Bhattarai MD, Maskey A: Demographic profile of diabetic patients admitted in medical wards of Bir Hospital, Nepal, 1990 to 1994. Intern Diabetes Digest Cambridge: FSG Commun Limited Intern Diabetes Fed. 1995, 64: 87-88.

    Google Scholar 

  28. Acharya GP: Diabetes mellitus at Tribhuvan University Teaching Hospital. Abstract Reports of International Symposium on Diabetes Mellitus, March 23–24. 1995, Nepal: Kathmandu, 7-

    Google Scholar 

  29. World Bank: Nepal at a Glance. 2007, World Bank: Washington, D.C

    Google Scholar 

  30. Thapa D, Sijapati B: A Kingdom under Siege: Nepal’s Maoist Insurgency, 1996 to 2003. 2004, Kathmandu/London: The Printhouse

    Google Scholar 

  31. Gautam S, Banskota A, Manchanda R: Where there are no men: women in the Maoist insurgency in Nepal. Women, War and Peace in South Asia: Beyond Victimhood to Agency. Edited by: Manchanda R. 2001, New Delhi: Sage Publications

    Google Scholar 

  32. Luitel NP, Jordans MJ, Sapkota RP, Tol WA, Kohrt BA, Thapa SB, Komproe IH, Sharma B: Conflict and mental health: a cross-sectional epidemiological study in Nepal. Soc Psychiatry Psychiatr Epidemiol. 2013, 48 (2): 183-193. 10.1007/s00127-012-0539-0.

    Article  PubMed  Google Scholar 

  33. Kohrt BA, Hruschka DJ, Worthman CM, Kunz RD, Baldwin JL, Upadhaya N, Acharya NR, Koirala S, Thapa SB, Tol WA, et al: Political violence and mental health in Nepal: prospective study. Br J Psychiatry. 2012, 201 (4): 268-275. 10.1192/bjp.bp.111.096222.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Kohrt BA, Worthman CM: Gender and anxiety in Nepal: the role of social support, stressful life events, and structural violence. CNS Neurosci Ther. 2009, 15: 237-248. 10.1111/j.1755-5949.2009.00096.x.

    Article  PubMed  Google Scholar 

  35. Kohrt BA, Speckman RA, Kunz RD, Baldwin JL, Upadhaya N, Acharya NR, Sharma VD, Nepal MK, Worthman CM: Culture in psychiatric epidemiology: using ethnography and multiple mediator models to assess the relationship of caste with depression and anxiety in Nepal. Ann Hum Biol. 2009, 36 (3): 261-280. 10.1080/03014460902839194.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Kohrt BA, Kunz RD, Baldwin JL, Koirala NR, Sharma VD, Nepal MK: “Somatization” and “Comorbidity”: a study of Jhum-Jhum and depression in rural Nepal. Ethos. 2005, 33 (1): 125-147. 10.1525/eth.2005.33.1.125.

    Article  Google Scholar 

  37. Lutsman PJ, Clouse RE, Griffith LS, Carney MSW, Freedland KERM: Screening for depression in diabetes using the Beck Depression Inventory. Psychosom Med. 1997, 59: 24-31.

    Article  Google Scholar 

  38. Kokoszka A: Depression in diabetes self-rating scale: a screening tool. Diabetologia. 2008, 8 (1): 43-47.

    Google Scholar 

  39. Kohrt BA, Kunz RD, Koirala NR, Sharma VD, Nepal MK: Validation of a Nepali version of the Beck Depression Inventory. Nepal J Psychiatry. 2002, 2 (4): 123-130.

    Google Scholar 

  40. Kohrt BA, Kunz RD, Koirala NR, Sharma VD, Nepal MK: Validation of the Nepali version of the Beck Anxiety Inventory. J Inst Med. 2003, 25 (1): 1-4.

    Google Scholar 

  41. Ali S, Stone MA, Peters JL, Davies MJ, Khunti K: The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2006, 23: 1165-1173. 10.1111/j.1464-5491.2006.01943.x.

    Article  CAS  PubMed  Google Scholar 

  42. Roy MS, Roy A, Affouf M: Depression is a risk factor for poor glycemic control and retinopathy in African- Americans with type 1 diabetes. Psychosom Med. 2007, 69 (6): 537-542. 10.1097/PSY.0b013e3180df84e2.

    Article  PubMed  Google Scholar 

  43. Larijani B, Khoram M, Bayat S, Gorgani MK, Bandarian F, Akhondzadeh S, et al: Association between depression and diabetes. Germ J Psychiatry. 2004, 7: 62-65.

    Google Scholar 

  44. Black SA, Markides KS, Ray LA: Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care. 2003, 26 (10): 2822-2828. 10.2337/diacare.26.10.2822.

    Article  PubMed  Google Scholar 

  45. Katon W, Von Korff M, Lin E, Simon G, Ludman E, Bush T, Walker E, Ciechanowski P, Rutter C: Improving primary care treatment of depression among patients with diabetes mellitus: the design of the pathways study. Gen Hosp Psychiatry. 2003, 25: 158-168. 10.1016/S0163-8343(03)00013-6.

    Article  PubMed  Google Scholar 

  46. Egede LE, Zheng D: Independent factors associated with major depressive disorder in a national sample of individuals with diabetes. Diabetes Care. 2003, 26: 104-111. 10.2337/diacare.26.1.104.

    Article  PubMed  Google Scholar 

  47. Peyrot M, Rubin RR: Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care. 1997, 20: 585-590. 10.2337/diacare.20.4.585.

    Article  CAS  PubMed  Google Scholar 

  48. Bell RA, Smith SL, Arcury TA, et al: Prevalence and correlates of depressive symptoms among rural older African Americans, Native Americans, and whites with diabetes. Diabetes Care. 2005, 28: 823-829. 10.2337/diacare.28.4.823.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Golden SH, Lazo M, Carnethon M, et al: Examining a bidirectional association between depressive symptoms and diabetes. JAMA. 2008, 299 (23): 2751-2759. 10.1001/jama.299.23.2751.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Kalsekar ID, Madhavan SS, Amonkar MM, Makela EH, Scott VG, Douglas SM, Elswick BLM: Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents. Ann Pharmacother. 2006, 40 (4): 605-611. 10.1345/aph.1G606.

    Article  PubMed  Google Scholar 

  51. Ciechanowski PS, Katon WJ, Russo JE: Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000, 160: 3278-3285. 10.1001/archinte.160.21.3278.

    Article  CAS  PubMed  Google Scholar 

  52. Sahota PK, Knowler HC, W.C: Looker, depression, diabetes, and glycemic control in an American Indian community. J Clin Psychiatry. 2008, 69 (5): 800-809. 10.4088/JCP.v69n0513.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Polonsky WH, Anderson BJ, Lohrer PA, Welch G, Jacobson AM, Aponte JE, Schwartz CE: Assessment of diabetes related distress. Diabetes Care. 1995, 18: 754-760. 10.2337/diacare.18.6.754.

    Article  CAS  PubMed  Google Scholar 

  54. Snoek FJ, Pouwer F, Welch GW, Polonsky WH: Diabetes-related emotional distress in Dutch and US diabetic patients: cross-cultural validity of the problem areas in diabetes scale. Diabetes Care. 2000, 23 (9): 1305-1309. 10.2337/diacare.23.9.1305.

    Article  CAS  PubMed  Google Scholar 

  55. Katon W, von Korff M, Ciechanowski P, Russo J, Lin E, Simon G, Ludman E, Walker E, Bush T, Young B: Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care. 2004, 27: 914-920. 10.2337/diacare.27.4.914.

    Article  PubMed  Google Scholar 

  56. Weaver LJ, Hadley C: Social pathways in the comorbidity between type 2 diabetes and mental health concerns in a pilot study of urban middle- and Upper-Class Indian Women. Ethos. 2011, 39 (2): 211-225. 10.1111/j.1548-1352.2011.01185.x.

    Article  Google Scholar 

  57. Kohrt BA: Vulnerable social groups in post-conflict settings: a mixed-methods policy analysis and epidemiology study of caste and psychological morbidity in Nepal. Intervention: International Journal of Mental Health, Psychosocial Work & Counselling in Areas of Armed Conflict. 2009, 7 (3): 239-264.

    Article  Google Scholar 

  58. Kohrt BA, Jordans MJD, Tol WA, Perera E, Karki R, Koirala S, Upadhaya N: Social ecology of child soldiers: child, family, and community determinants of mental health, psychosocial well-being, and reintegration in Nepal. Transcult Psychiatry. 2010, 47 (5): 727-753. 10.1177/1363461510381290.

    Article  PubMed  Google Scholar 

  59. Kohrt BA, Jordans MJD, Tol WA, Speckman RA, Maharjan SM, Worthman CM, Komproe IH: Comparison of mental health between former child soldiers and children never conscripted by armed groups in Nepal. JAMA. 2008, 300 (6): 691-702. 10.1001/jama.300.6.691.

    Article  CAS  PubMed  Google Scholar 

  60. Egede LE, Zheng D, Simpson K: Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care. 2002, 25: 464-470. 10.2337/diacare.25.3.464.

    Article  PubMed  Google Scholar 

  61. Everson SA, Maty SC, Lynch JW, Kaplan GA: Epidemiologic evidence for the relation between socioeconomic status and depression, obesity, and diabetes. J Psychosom Res. 2002, 53: 891-895. 10.1016/S0022-3999(02)00303-3.

    Article  PubMed  Google Scholar 

  62. Mendenhall E, Shivashankar R, Tandon N, Ali MK, Narayan KMV, Prabhakaran D: Stress and diabetes in socioeconomic context: A qualitative study of urban Indians. Soc Sci Med. 2012, 75 (12): 2522-2529. 10.1016/j.socscimed.2012.09.040.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Leone T, Coast E, Narayanan S, de Graft AA: Diabetes and depression comorbidity and socio-economic status in low and middle income countries (LMICs): a mapping of the evidence. Global Health. 2012, 8 (39): 1-10.

    Google Scholar 

  64. Popkin BM, Adair LS, Ng SW: Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev. 2012, 70 (1): 3-21. 10.1111/j.1753-4887.2011.00456.x.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Subramanian S, Smith GD: Patterns, distribution, and determinants of under-and overnutrition: a population-based study of women in India. Am J Clin Nutr. 2006, 84 (3): 633-640.

    CAS  PubMed  Google Scholar 

  66. Johnson JA, Al Sayah F, Wozniak L, Rees S, Soprovich A, Chik CL, Chue P, Florence P, Jacquier J, Lysak P, et al: Controlled trial of a collaborative primary care team model for patients with diabetes and depression: rationale and design for a comprehensive evaluation. BMC Health Serv Res. 2012, 12: 258-10.1186/1472-6963-12-258.

    Article  PubMed  PubMed Central  Google Scholar 

  67. van Dijk S, Pols A, Adriaanse M, Bosmans J, Elders P, van Marwijk H, van Tulder M: Cost-effectiveness of a stepped-care intervention to prevent major depression in patients with type 2 diabetes mellitus and/or coronary heart disease and subthreshold depression: design of a cluster-randomized controlled trial. BMC Psychiatry. 2013, 13 (1): 128-10.1186/1471-244X-13-128.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Atkins J, Naismith S, Luscombe G, Hickie I: A preliminary study of aged care facility staff indicates limitations in awareness of the link between depression and physical morbidity. BMC Geriatr. 2013, 13 (1): 30-10.1186/1471-2318-13-30.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Kohrt BA, Maharjan SM, Timsina D, Griffith JL: Applying Nepali ethnopsychology to psychotherapy for the treatment of mental illness and prevention of suicide among Bhutanese refugees. Annals of Anthropological Practice. 2012, 36 (1): 88-112. 10.1111/j.2153-9588.2012.01094.x.

    Article  Google Scholar 

  70. Walsh R: Lifestyle and mental health. Am Psychol. 2011, 66 (7): 579-

    Article  PubMed  Google Scholar 

Pre-publication history

Download references

Acknowledgements

This study was funded by the Norwegian Award for Masters Studies (NOMA) through Oslo University, Norway, awarded to Bangladesh University of Health Sciences, Bangladesh (Bangladesh Institute of Health Sciences: during the study period). Thanks to Professor Akthar Hussain, Department of International Health, University of Oslo, focal person for funding support. The second author was supported through a supplemental grant to the South Asia Hub for Advocacy, Research, and Education on Mental Health (SHARE), PIs: Vikram Patel and Atif Rahman (NIMH U19MH095687-S1). The following individuals provided invaluable support at different stages of the research: Professor Liaquat Ali, Vice Chancellor Bangladesh University of Health Sciences; from the Department of Epidemiology and Biostatistics, Bangladesh University of Health Sciences: Professor M.A. Hafez, Dr. M. Shahjahan, Dr. Sabiha Sultana, Farzana Rahman, Nurunnahar Sumi, Afsana Afroz; Professor Clare Bradley (University of London); Professor David M. Nathan (Harvard Medical School); Professor U.N. Pathak, Head Department of Medicine, Nepal Medical College and Teaching Hospital; Professor K.P. Singh, Director, Tribhuvan University Teaching Hospital; Professor Sashi Sharma, head department of medicine, Tribhuvan University Teaching Hospital; Dr. Hari Kishor Shrestha, Director, Om Hospital and Research Center; Dr. Rajesh Kishor Shrestha, Acting Director, Nepal Medical College and Teaching Hospital; Dr. Mahbubur Rahman, National Institute of Preventive and Social Medicine, Dhaka, Bangladesh; Prof. Supten Sarbadhikari, Dr. Zahara Ali Rizvi, Janaki Parajuli, Dr. Kalyan Bhowmik, Bangladesh University of Health Sciences; Prof. Faisal Masud, Prof. Asad Aslam Khan, Prof. M. Ashraf Shaheen, Dr. Abdul Hameed, Dr. Muhammad Tariq, Dr. Laeeq Ur Rehman, Dr. Irfan Sheikh, King Edward Medical University. We are grateful to Emily Mendenhall and Lesley Jo Weaver for reviewing the manuscript and providing unique insights that we crucial in the revision process.

Author information

Authors and Affiliations

  1. Department of Epidemiology and Biostatistics, Bangladesh University of Health Sciences (BUHS), Dhaka, Bangladesh

    Kiran Niraula

  2. Department of Neurosurgery, King Edward Medical University (KEMU)/Mayo Hospital, Lahore, Pakistan

    Kiran Niraula

  3. Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA

    Brandon A Kohrt

  4. Duke Global Health Institute, Duke University, Durham, NC, USA

    Brandon A Kohrt & Elizabeth K MacFarlane

  5. Department of Epidemiology, National Institute of Preventive and Social Medicine, Dhaka, Bangladesh

    Meerjady Sabrina Flora

  6. Department of Community Medicine, Nepalese Army Institute of Health Sciences, Kathmandu, Nepal

    Narbada Thapa

  7. Department of Epidemiology, Bangladesh University of Health Sciences, Dhaka, Bangladesh

    Shirin Jahan Mumu

  8. Institute of Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal

    Rahul Pathak

  9. Institute of Clinical Medicine, University of Oslo - Division of Women and Children, Rikshospitalet, Oslo University Hospital, Oslo, Norway

    Babill Stray-Pedersen

  10. Nepal Medical College, Kathmandu, Nepal

    Pukar Ghimire

  11. Om Hospital and Research Center, Kathmandu, Nepal

    Bhawana Regmi

  12. Kathmandu Medical College, Kathmandu, Nepal

    Roshni Shrestha

Authors
  1. Kiran Niraula
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brandon A Kohrt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Meerjady Sabrina Flora
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Narbada Thapa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shirin Jahan Mumu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rahul Pathak
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Babill Stray-Pedersen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Pukar Ghimire
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Bhawana Regmi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Elizabeth K MacFarlane
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Roshni Shrestha
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kiran Niraula.

Additional information

Competing interests

The authors declare no financial or non-financial competing interests.

Authors’ contributions

KN designed the study, performed data collection, data analysis and drafted the manuscript. BK performed data analysis and drafted the manuscript. MSF contributed in conception, design and interpretation of data. NT revised the article critically and gave valuable suggestions. SJM helped in data analysis, literature search, and interpretation of data. RP contributed in acquisition of data and helped in analysis. BP helped in conception and design. PG, BR, RS contributed in acquisition of data, drafting articles and reviewed the article before submission to publishers. KN, BK, and EM significantly revised the manuscript. All authors read and approved the final manuscript.

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Niraula, K., Kohrt, B.A., Flora, M.S. et al. Prevalence of depression and associated risk factors among persons with type-2 diabetes mellitus without a prior psychiatric history: a cross-sectional study in clinical settings in urban Nepal. BMC Psychiatry 13, 309 (2013). https://doi.org/10.1186/1471-244X-13-309

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/1471-244X-13-309

Keywords

BMC Psychiatry

ISSN: 1471-244X

Contact us